Search Results - "Bykovskaya, S N"

Treatment with Ex Vivo Expanded Autologous Regulatory CD4+CD25+Foxp3+CD127low T Cells Restores the Balance of the Immune System in Patients with Remitting Multiple Sclerosis by Eliseeva, D. D., Lifshits, G. V., Lokhonina, A. V., Zhdanov, D. D., Zavalishin, I. A., Bykovskaya, S. N.

“…Objective. To assess the clinical efficacy and safety of autologous (patient’s own) T reg cells – CD4 + CD25 + Foxp3 + CD127 low – isolated from the blood of…”
Get full text

Retinopathy of prematurity: indicators of cellular immunity in patients with various stages of the disease by Balashova, L. M., Kuznetsova, Y. D., Korobova, L. S., Kantarzhi, E. P., Mukhin, V. E., Cherkashina, E. A., Bykovskaya, S. N.

“…Purpose: to study the role of cellular immunity in the development of retinopathy of prematurity (ROP). Material and methods. 87 children were tested,…”
Get full text

Neural Progenitor and Hemopoietic Stem Cells Inhibit the Growth of Low-Differentiated Glioma by Baklaushev, V. P., Grinenko, N. F., Savchenko, E. A., Bykovskaya, S. N., Yusubalieva, G. M., Viktorov, I. V., Bryukhovetskii, A. S., Bryukhovetskii, I. S., Chekhonin, V. P.

“…The effects of neural progenitor and hemopoietic stem cells on C6 glioma cells were studied in in vivo and in vitro experiments. Considerable inhibition of…”
Get full text

ROLE OF MULTIPLEX CYTOKINE ANALYSIS IN THE EVALUATION OF THE EFFICACY OF RITUXIMAB DURING TREATMENT FOR RHEUMATOID ARTHRITIS by Novikov, A. A., Aleksandrova, E. N., Popkova, T. V., Lineva, O. G., Avdeyeva, A. S., Novikova, D. S., Kuzikyants, G. Kh, Lukina, G. V., Sigidin, Ya. A., Karaulov, A. V., Bykovskaya, S. N., Nasonov, E. L.

“…Along with its basic activity in removing B-lymphocytes, rituximab (RTM) causes depletion of a population of CD20+ T cells that can pro- duce a variety of…”
Get full text

Role of the regulatory T cells CD4+CD25+ and mesenchymal marrow stem cells in suppressing a graft versus host reaction by I. A. Korsunsky, A. G. Rumyantsev, S. N. Bykovskaya

“…A graft versus host disease (GVHD) is one of the most serious complications occurring after allogeneic marrow cell transplantation. The investigation of the…”
Get full text

Discrepancy between direct and antibody-dependent cytotoxic activities of human LAK cells by Potapnev, M P, Garbuzenco, T S, Goncharova, N V, Zobnin, V D, Shadrin, O V, Bykovskaya, S N

“…Human lymphokine-activated killer (LAK) cells display cytotoxic activity against natural killer (NK)-resistant tumor cells in an antibody-independent and…”
Get more information

Recombinant interleukin-2 significantly increases the survival of mice with peritonitis, but not acute Staphylococcus aureus peritoneal infection by Shadrin, O V, Kaufman, O Y, Dronova, O M, Bykovskaya, S N

“…The effect of recombinant interleukin 2 (rIL-2) on survival of mice with peritonitis and acute Staphylococcus aureus strain 5/2 infection was studied. rIL-2…”
Get more information

Cytotoxic activity of murine platelets by Tuguz, A. R., Kiselevskii, M. V., Senin, V. M., Babaskina, L. I., Afanas'eva, A. V., Golubeva, T. S., Trishin, A. V., Bykovskaya, S. N.

“…Platelets of intact mice and mice with tumors posses cytotoxic activity towards autologous and allogenic tumor strains. Platelet cytotoxicity significantly…”
Get full text

Platelet-mediated cytotoxicity and its enhancement by platelet activating factor by Bykovskaya, S N, Bolvacheva, A V, Kiselevsky, M V, Khaylenko, V A, Bykovsky, A F

“…Platelet cytotoxicity was assessed in 70 cancer patients with various tumor localizations and in 30 normal donors. The data presented reveal that the ACL cell…”
Get more information

Treatment with interleukin-2 in an immunodepressed state by Bykovskaya, S N, Abronina, I F, Kypriyanova, T A, Malachova, N V

“…Cytotoxic T-lymphocyte (CTL) and lymphokine activated killer (LAK) cell (fraction II) precursors with a density of 1.077-1.067 g/ml and suppressor cells…”
Get more information

Proliferative activity, lectin-dependent and natural cytotoxicity in blood, lymph node and spleen from patients with Hodgkin's disease by Bykovskaya, S N, Blochina, N G, Charabadze, M V, Agaphonov, V A, Kupriyanova, T A

“…Mononuclear cells and T-lymphocytes of the blood, spleen and lymph nodes from 48 patients with Hodgkin disease (HD) and blood donors were tested in assays for…”
Get more information

Regulatory T-cells CD4+CD25+Foxр3+ in patients with remitting multiple sclerosis by D. D. Eliseeva, I. A. Zavalishin, S. N. Bykovskaya, T. N. Fedorova, E. N. Karandashov, O. A. Trunova

“…In the maintenance of immunological tolerance a recently discoveredpopulation of regulatory T-cells CD4+CD25+Foxp3+(Treg) plays an important role. These cells…”
Get full text

Activation of secretion and surface alteration of cytolytic T-lymphocytes interacting with target cells by Bykovskaya, S N, Shevelev, A A, Kupriyanova, T A

“…Cells obtained in mixed lymphocyte culture (MLC) and memory cells adsorbed on the surface of target cells (TC) were examined using scanning and transmission…”
Get more information

Clinical significance of T-regulatory cells in multiple sclerosis by Eliseeva, D D, Zavalishin, I A, Bykovskaia, S N

“…Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system that develops due to the activation of selfreactive T-cells…”
Get more information

The role of regulatory T cells in the development of autoimmune process in multiple sclerosis by Eliseeva, D D, Zavalishin, I A, Karaulov, A V, Bykovskaia, S N

“…In the maintenance of immunological tolerance important role belongs to the recently discovered population of regulatory T-cells CD4+CD25+FoxP3 +. These cells…”
Get more information

Block copolymers of ethylene oxide and propylene oxide (pluronics) as immunomodulators and antitumour agents by Topchieva, I N, Erokhin, V N, Osipova, S V, Khrutskaya, M M, Kupriyanova, T A, Bykovskaya, S N

“…Block copolymers of ethylene oxide and propylene oxide (pluronics) are nontoxic water-soluble membranotropic surfactants available as polymers with various…”
Get more information

Down-regulation of LAK cell-mediated cytotoxicity: cancer and ageing by Bykovskaya, S N, Abronina, I F, Kupriyanova, T A, Bubenik, J

“…A comparative study was made of the generation of lymphokine-activated killer (LAK) cells in patients with melanoma and healthy donors of different age groups…”
Get more information

Effect of lymphokines on platelet-mediated cytotoxicity by Malakhova, N. V., Kiselevskii, M. V., Cherepovskii, D. N., Vorob'ev, A. A., Bykovskaya, S. N.

Get full text

Radioprotective action of lymphokinin, a composite preparation of cytokines by Boiko, V. N., Shadrin, O. V., Derevyanchenko, I. G., Buntsevich, A. M., Bykovskaya, S. N.

Get full text

The influence of tumor immunity suppressors on the effector stage of human and animal lymphokine-activated killer cells by Abronina, I F, Indrova, M, Bubenic, J, Figurin, K M, Malakhova, N V, Bykovskaya, S N

“…Spleen cells of tumor-bearing mice suppressed the cytolytic activity of syngeneic LAK cells when added to the mixture of LAK cells and target cells at the…”
Get more information